SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes

By sjmartinez • January 13, 2025

Bhatti AW, Patel R, Dani SS, Khadke S, Makwana B, Lessey C, Shah J, Al-Husami Z, Yang EH, Thavendiranathan P, Neilan TG, Sadler D, Cheng RK, Dent SF, Liu J, Lopez-Fernandez T, Herrmann J, Scherrer-Crosbie M, Lenihan DJ, Hayek SS, Ky B, Deswal A, Barac A, Nohria A, Ganatra S. SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes. JACC CardioOncol. 2024 Sep 22;6(6):863-875. doi: 10.1016/j.jaccao.2024.08.001. PMID: 39801650; PMCID: PMC11711834.

Tags: antineoplastic therapy, Cardiology/Epi, cardiomyopathy, CTRCD, primary prevention, Publications, sodium glucose co-transporter 2 inhibitors

Related Posts

Ethnic differences in coronary plaque burden and characteristics: A matched CCTA cohort study of South Asians and non-Hispanic Whites

Manubolu VS, Kinninger A, Lakshmanan S, Dahal S, Ichikawa K, Verghese D, Alalawi L, Aldana J, Susarla S, Seok HJ, Dailing C, Roy SK, Rohatgi[...]

Biomimetic, Suturable, and Extensible Electrospun Scaffolds for Lower Urinary Tract Surgical Reconstruction

Sturm RM, Huo Y, Yiu F, Gu Y, Afshari R, Zhong Z, Jimenez R, Jung R, Cabuan A, Shukla K, Harrison K, Su J, Aninwene[...]

Machine learning-assisted point-of-care diagnostics for cardiovascular healthcare

Wang K, Tan B, Wang X, Qiu S, Zhang Q, Wang S, Yen YT, Jing N, Liu C, Chen X, Liu S, Yu Y. Machine[...]